A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 31/7105 (2006.01) A61K 38/16 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2762176
The present invention pertains to methods and agents that target nanog expression or activity for treating or preventing cancer. Alternative methods involve diagnosing cancer stage or type by identifying presence of cancer cells expressing nanog. Other embodiments relate to methods of identifying agents that modulate nanog.
Cette invention concerne des procédés et des agents qui ciblent l'expression ou l'activité de nanog pour traiter ou prévenir le cancer. D'autres procédés impliquent le diagnostic du stade ou du type de cancer par identification de la présence de cellules cancéreuses exprimant nanog. D'autres modes de réalisation concernent des procédés permettant d'identifier des agents qui modulent nanog.
Sugaya Kiminobu
Gowling Lafleur Henderson Llp
University Of Central Florida Research Foundation Inc.
LandOfFree
Marker differentially expressed in cancer stem cells and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Marker differentially expressed in cancer stem cells and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Marker differentially expressed in cancer stem cells and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2043614